Marwan Almoiliqy

586 total citations
28 papers, 397 citations indexed

About

Marwan Almoiliqy is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marwan Almoiliqy has authored 28 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marwan Almoiliqy's work include Curcumin's Biomedical Applications (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Medicinal Plants and Neuroprotection (2 papers). Marwan Almoiliqy is often cited by papers focused on Curcumin's Biomedical Applications (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Medicinal Plants and Neuroprotection (2 papers). Marwan Almoiliqy collaborates with scholars based in China, Saudi Arabia and Yemen. Marwan Almoiliqy's co-authors include Jin Wen, Dapeng Chen, Mengqiao Lian, Bin Xu, Yuan Lin, Yuchao Sun, Yanli Li, Yun-Peng Diao, Li Wang and Eskandar Qaed and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and Talanta.

In The Last Decade

Marwan Almoiliqy

25 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marwan Almoiliqy China 11 167 67 52 49 47 28 397
Chia‐Yao Shen Taiwan 12 218 1.3× 68 1.0× 44 0.8× 25 0.5× 47 1.0× 18 412
Sudhir Pandey Taiwan 14 229 1.4× 51 0.8× 43 0.8× 34 0.7× 58 1.2× 30 427
Shengjun Fan China 14 274 1.6× 59 0.9× 44 0.8× 41 0.8× 53 1.1× 19 493
Dan Song China 14 180 1.1× 70 1.0× 32 0.6× 26 0.5× 54 1.1× 41 497
Zhaohui Qiu China 14 249 1.5× 105 1.6× 72 1.4× 39 0.8× 65 1.4× 28 553
Xianshe Meng China 6 157 0.9× 68 1.0× 85 1.6× 31 0.6× 36 0.8× 9 385
Shu Dai China 13 193 1.2× 61 0.9× 25 0.5× 41 0.8× 86 1.8× 24 452
Kolsoum Rezaie Kahkhaie Iran 6 202 1.2× 65 1.0× 38 0.7× 33 0.7× 30 0.6× 11 425
Yanting You China 13 234 1.4× 39 0.6× 36 0.7× 42 0.9× 40 0.9× 36 517

Countries citing papers authored by Marwan Almoiliqy

Since Specialization
Citations

This map shows the geographic impact of Marwan Almoiliqy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Almoiliqy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Almoiliqy more than expected).

Fields of papers citing papers by Marwan Almoiliqy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Almoiliqy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Almoiliqy. The network helps show where Marwan Almoiliqy may publish in the future.

Co-authorship network of co-authors of Marwan Almoiliqy

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Almoiliqy. A scholar is included among the top collaborators of Marwan Almoiliqy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Almoiliqy. Marwan Almoiliqy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qaed, Eskandar, et al.. (2025). Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways. Tissue and Cell. 96. 103013–103013.
5.
Qaed, Eskandar, et al.. (2024). Evaluating the pharmacological activities of Aloe perryi–Silver nanoparticles induced apoptosis against colon cancer cells (HCT‐116). Food Science & Nutrition. 12(8). 5890–5906. 1 indexed citations
6.
Qaed, Eskandar, et al.. (2024). Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3321–3343. 2 indexed citations
7.
Qaed, Eskandar, Mohamed Y. Zaky, Marwan Almoiliqy, et al.. (2024). Uncovering the Therapeutic Potential of Phosphocreatine in Diabetic Retinopathy: Mitigating Mitochondrial Dysfunction and Apoptosis via JAK2/STAT3 Signaling Pathway. Journal of Molecular Neuroscience. 74(1). 11–11. 3 indexed citations
8.
Zaky, Mohamed Y., Marwan M. A. Rashed, Marwan Almoiliqy, et al.. (2024). UPLC-qTOF-MS phytochemical profile of Commiphora gileadensis leaf extract via integrated ultrasonic-microwave-assisted technique and synthesis of silver nanoparticles for enhanced antibacterial properties. Ultrasonics Sonochemistry. 107. 106923–106923. 7 indexed citations
9.
Qaed, Eskandar, et al.. (2023). Procyanidins: A promising anti‐diabetic agent with potential benefits on glucose metabolism and diabetes complications. Wound Repair and Regeneration. 31(5). 688–699. 10 indexed citations
10.
Rashed, Marwan M. A., Marwan Almoiliqy, Mohanad Bashari, et al.. (2023). Antioxidant activity and total phenolic compounds of Commiphora gileadensis extracts obtained by ultrasonic‐assisted extraction, with monitoring antiaging and cytotoxicity activities. Food Science & Nutrition. 11(6). 3506–3515. 8 indexed citations
11.
Safi, Mohammed, et al.. (2022). Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson s Disease. 2022(1). 2700227–2700227. 17 indexed citations
12.
Safi, Mohammed, et al.. (2022). Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study. Therapeutic Advances in Urology. 14. 3623425969–3623425969. 8 indexed citations
13.
Wen, Jin, Marwan Almoiliqy, Yaojia Wang, et al.. (2021). Sesamin Protects against and Ameliorates Rat Intestinal Ischemia/Reperfusion Injury with Involvement of Activating Nrf2/HO‐1/NQO1 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 5147069–5147069. 27 indexed citations
14.
Almoiliqy, Marwan, et al.. (2021). Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States. Oxidative Medicine and Cellular Longevity. 2021(1). 9999529–9999529. 1 indexed citations
15.
Shopit, Abdullah, Xiaodong Li, Zhongyuan Tang, et al.. (2020). miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis. Pharmacological Research. 161. 105130–105130. 24 indexed citations
16.
Zhang, Xinsheng, Xiaomeng Li, Abdullah Shopit, et al.. (2020). MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A. Cancer Cell International. 20(1). 62–62. 13 indexed citations
17.
Almoiliqy, Marwan, Jin Wen, Bin Xu, et al.. (2020). Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53. Acta Pharmacologica Sinica. 41(9). 1208–1222. 44 indexed citations
18.
Almoiliqy, Marwan, Jin Wen, Eskandar Qaed, et al.. (2020). Protective Effects of Cinnamaldehyde against Mesenteric Ischemia-Reperfusion-Induced Lung and Liver Injuries in Rats. Oxidative Medicine and Cellular Longevity. 2020. 1–14. 11 indexed citations
19.
Wen, Jin, Bin Xu, Yuchao Sun, et al.. (2019). Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy. Pharmacological Research. 146. 104308–104308. 98 indexed citations
20.
Sun, Yuchao, Mengqiao Lian, Yuan Lin, et al.. (2017). Role of p-MKK7 in myricetin-induced protection against intestinal ischemia/reperfusion injury. Pharmacological Research. 129. 432–442. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026